Daiichi Sankyo
Daiichi Sankyo Company, Limited, commonly referred to as Daiichi Sankyo, is a prominent global pharmaceutical company headquartered in the United States. Founded in 2005 through the merger of Daiichi Pharmaceutical and Sankyo Company, Limited, the company has established a strong presence in key operational regions, including Japan, Europe, and Asia. Specialising in innovative medicines, Daiichi Sankyo focuses on oncology, cardiovascular diseases, and vaccines, offering unique products that leverage cutting-edge research and development. The company is recognised for its commitment to advancing healthcare solutions, with notable achievements in drug discovery and development. With a robust pipeline and a reputation for excellence, Daiichi Sankyo continues to strengthen its market position, striving to improve patient outcomes worldwide through its high-quality pharmaceutical offerings.
DitchCarbon Score
How does Daiichi Sankyo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Daiichi Sankyo's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Daiichi Sankyo's reported carbon emissions
Daiichi Sankyo, headquartered in the US, currently does not provide specific carbon emissions data or reduction targets. Without available figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the company is expected to align with industry standards and best practices regarding climate action. As the pharmaceutical sector increasingly focuses on sustainability, Daiichi Sankyo may be involved in initiatives aimed at reducing emissions and enhancing environmental responsibility. Further information on their specific commitments or achievements in this area would be beneficial for a comprehensive understanding of their climate strategy.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Daiichi Sankyo is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
